New therapy for HIV treatment

July 29, 2008

Millions of people world-wide who have contracted a highly resistant strain of the HIV virus could benefit from a new drug to treat the infection.

Research co-authored by the University of New South Wales' (UNSW) National Centre in HIV Epidemiology and Clinical Research (NCHECR) shows that the majority of patients who have not responded to traditional treatments have had good results from a new combination therapy.

The drug raltegravir is already available in Australia and was listed on the Pharmaceutical Benefits Scheme on July 1st, with clinical trials showing that it is safe, effective and with minimal side-effects when used with other anti-HIV medicines.

The study, which has been published in the New England Journal of Medicine, shows the raltegravir effectively lowers the amount of virus in the blood to undetectable levels in 62 percent of people taking it in combination with other anti-HIV medicines.

Only one in three people who received a placebo plus other anti-HIV medicines had the amount of virus in the blood reduced to similar levels.

"This is the first drug in a new class of antiretroviral drugs called integrase inhibitors," said UNSW Professor David Cooper AO, the Director of NCHECR .

"The drug has a different mechanism of action, is very potent, seems very safe and has helped patients who have a virus that is resistant to older drugs and classes," said Professor Cooper.

"It initially will be used in developed countries, but hopefully, it will be made available at cheaper prices for patients in developing countries who are facing the same problems," said Professor Cooper.

The results were based on analyses of viral load reductions and CD4 cell count increases. A high CD4 cell count is crucial for a healthy immune system.

Professor Cooper said the efficacy shown at 48 weeks of treatment was consistent with observations at 24 weeks, indicating that the drug in combination has a durable effect.

The study shows the drug is well-tolerated by patients. It showed that only 0.9 percent of those receiving raltegravir discontinued therapy due to side-effects including nausea and headaches.

Source: University of New South Wales

3.7 /5 (7 votes)  

Rank 3.7 /5 (7 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

How early breast tumors become deadly: A small group of molecules might hold the answer

Researchers have discovered a restricted pattern of molecules that differentiate early-stage breast tumors from invasive, life-threatening cancer. They also found a similar molecular signature that correlated with the aggressiveness ...

Medicine & Health / Cancer

created 10 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Scientists use an old theory to discover new targets in the fight against breast cancer

Reviving a theory first proposed in the late 1800s that the development of organs in the normal embryo and the development of cancers are related, scientists at the Salk Institute for Biological Studies have ...

Medicine & Health / Cancer

created 10 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Green tea found to reduce disability in the elderly

(Medical Xpress) -- A lot of research has been done over the past several years looking into the health benefits of green tea. As a result, scientists have found that regular consumption of the beverage leads ...

Medicine & Health / Health

created 17 hours ago | popularity 4.9 / 5 (8) | comments 7 | with audio podcast report

Parkinson's disease: Study of live human neurons reveals the disease's genetic origins

Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure.

Medicine & Health / Genetics

created 15 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

Warning! Collision imminent! The brain's quick interceptions help you navigate the world

Researchers at The Neuro and the University of Maryland have figured out the mathematical calculations that specific neurons employ in order to inform us of our distance from an object and the 3-D velocities of moving objects ...

Medicine & Health / Neuroscience

created 16 hours ago | popularity 5 / 5 (5) | comments 1 | with audio podcast


Scientists develop biological computer to encrypt and decipher images

Scientists at The Scripps Research Institute in California and the Technion–Israel Institute of Technology have developed a "biological computer" made entirely from biomolecules that is capable of deciphering ...

Mars-bound NASA rover carries coin for camera checkup

(PhysOrg.com) -- The camera at the end of the robotic arm on NASA's Mars rover Curiosity has its own calibration target, a smartphone-size plaque that looks like an eye chart supplemented with color chips ...

Entire genome of extinct human decoded from fossil

(PhysOrg.com) -- In 2010, Svante Pääbo and his colleagues presented a draft version of the genome from a small fragment of a human finger bone discovered in Denisova Cave in southern Siberia. The ...

Physicists 'record' magnetic breakthrough

An international team of scientists has demonstrated a revolutionary new way of magnetic recording which will allow information to be processed hundreds of times faster than by current hard drive technology.

Haptic cube lets you feel tomorrow's temps

(PhysOrg.com) -- Will it be an invention joining a storage room of other inventions? Or kicked further up to gadget boutiques for the very rich? Or a popular gadget for many worldwide? Whatever its destiny, ...

Computer security firm Symantec extorted by hackers

Computer security firm Symantec on Tuesday confirmed it tried to turn the tables on hackers who threatened to release stolen source code if a demand for $50,000 was not met.